109 related articles for article (PubMed ID: 11337059)
1. LDL-induced association of anionic liposomes with cells and delivery of contents. II. Interaction of liposomes with cells in serum-containing medium.
Amin K; Heath TD
J Control Release; 2001 May; 73(1):49-57. PubMed ID: 11337059
[TBL] [Abstract][Full Text] [Related]
2. LDL induced association of anionic liposomes with cells and delivery of contents as shown by the increase in potency of liposome dependent drugs.
Amin K; Ng KY; Brown CS; Bruno MS; Heath TD
Pharm Res; 2001 Jul; 18(7):914-21. PubMed ID: 11496949
[TBL] [Abstract][Full Text] [Related]
3. Cell association of liposomes with high fluid anionic phospholipid content is mediated specifically by LDL and its receptor, LDLr.
Amin K; Wasan KM; Albrecht RM; Heath TD
J Pharm Sci; 2002 May; 91(5):1233-44. PubMed ID: 11977099
[TBL] [Abstract][Full Text] [Related]
4. Leakage and delivery of liposome-encapsulated methotrexate-gamma-aspartate in a chemically defined medium.
Comiskey SJ; Heath TD
Biochim Biophys Acta; 1990 May; 1024(2):307-17. PubMed ID: 2354182
[TBL] [Abstract][Full Text] [Related]
5. Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density.
Lee KD; Hong K; Papahadjopoulos D
Biochim Biophys Acta; 1992 Jan; 1103(2):185-97. PubMed ID: 1543703
[TBL] [Abstract][Full Text] [Related]
6. Liposome dependent delivery of S-adenosyl methionine to cells by liposomes: a potential treatment for liver disease.
Wagner EJ; Krugner-Higby L; Heath TD
J Pharm Sci; 2009 Feb; 98(2):573-82. PubMed ID: 18642386
[TBL] [Abstract][Full Text] [Related]
7. The effects of liposome size and surface charge on liposome-mediated delivery of methotrexate-gamma-aspartate to cells in vitro.
Heath TD; Lopez NG; Papahadjopoulos D
Biochim Biophys Acta; 1985 Oct; 820(1):74-84. PubMed ID: 3876848
[TBL] [Abstract][Full Text] [Related]
8. Temperature-dependent interaction of thermo-sensitive polymer-modified liposomes with CV1 cells.
Kono K; Nakai R; Morimoto K; Takagishi T
FEBS Lett; 1999 Aug; 456(2):306-10. PubMed ID: 10456329
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein E-enriched liposomes.
Versluis AJ; Rensen PC; Rump ET; Van Berkel TJ; Bijsterbosch MK
Br J Cancer; 1998 Dec; 78(12):1607-14. PubMed ID: 9862571
[TBL] [Abstract][Full Text] [Related]
10. Cellular retention of liposome-delivered anionic compounds modulated by a probenecid-sensitive anion transporter.
Oh YK; Straubinger RM
Pharm Res; 1997 Sep; 14(9):1203-9. PubMed ID: 9327449
[TBL] [Abstract][Full Text] [Related]
11. Stable incorporation of a lipophilic daunorubicin prodrug into apolipoprotein E-exposing liposomes induces uptake of prodrug via low-density lipoprotein receptor in vivo.
Versluis AJ; Rump ET; Rensen PC; van Berkel TJ; Bijsterbosch MK
J Pharmacol Exp Ther; 1999 Apr; 289(1):1-7. PubMed ID: 10086980
[TBL] [Abstract][Full Text] [Related]
12. Modulation of human ovarian tumor cell sensitivity to N-(phosphonacetyl)-L-aspartate (PALA) by liposome drug carriers.
Sharma A; Straubinger NL; Straubinger RM
Pharm Res; 1993 Oct; 10(10):1434-41. PubMed ID: 8272404
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of a lipophilic daunorubicin derivative and its incorporation into lipidic carriers developed for LDL receptor-mediated tumor therapy.
Versluis AJ; Rump ET; Rensen PC; Van Berkel TJ; Bijsterbosch MK
Pharm Res; 1998 Apr; 15(4):531-7. PubMed ID: 9587947
[TBL] [Abstract][Full Text] [Related]
14. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
[TBL] [Abstract][Full Text] [Related]
15. Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity.
Liu M; Li W; Larregieu CA; Cheng M; Yan B; Chu T; Li H; Mao SJ
Mol Pharm; 2014 Jul; 11(7):2305-12. PubMed ID: 24830852
[TBL] [Abstract][Full Text] [Related]
16. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro.
Mönkkönen J; Taskinen M; Auriola SO; Urtti A
J Drug Target; 1994; 2(4):299-308. PubMed ID: 7858955
[TBL] [Abstract][Full Text] [Related]
18. Conjugation of apolipoprotein B with liposomes and targeting to cells in culture.
Lundberg B; Hong K; Papahadjopoulos D
Biochim Biophys Acta; 1993 Jul; 1149(2):305-12. PubMed ID: 8391843
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents.
Rensen PC; Schiffelers RM; Versluis AJ; Bijsterbosch MK; Van Kuijk-Meuwissen ME; Van Berkel TJ
Mol Pharmacol; 1997 Sep; 52(3):445-55. PubMed ID: 9281607
[TBL] [Abstract][Full Text] [Related]
20. Development of magnetic anionic liposome/atelocollagen complexes for efficient magnetic drug targeting.
Kono Y; Nakai T; Taguchi H; Fujita T
Drug Deliv; 2017 Nov; 24(1):1740-1749. PubMed ID: 29141461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
